RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents-Reference-Cited by-同舟云学术

RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents

Published:2012-01-06 Issue:1 Volume:341 Page:90-103
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Xu Daigen,Kim Yong,Postelnek Jennifer,Vu Minh Diem,Hu Dong-Qing,Liao Cheng,Bradshaw Mike,Hsu Jonathan,Zhang Jun,Pashine Achal,Srinivasan Dinesh,Woods John,Levin Anita,O'Mahony Alison,Owens Timothy D.,Lou Yan,Hill Ronald J.,Narula Satwant,DeMartino Julie,Fine Jay S.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Characterization of compound mechanisms and secondary activities by BioMAP analysis

2. Chemical target and pathway toxicity mechanisms defined in primary human cell systems

3. Induction of macrophage secretion of tumor necrosis factor α through Fcγ receptor IIa engagement by rheumatoid arthritis–specific autoantibodies to citrullinated proteins complexed with fibrinogen

4. X-Linked Agammaglobulinemia: New Approaches to Old Questions based on the Identification of the Defective Gene

5. Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes;Debets;J Immunol,1988

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Methylated Cyclodextrin KLEPTOSE® CRYSMEB on Inflammatory Responses in Human In Vitro Models;International Journal of Molecular Sciences;2024-09-09

2. Characterization of a small molecule inhibitor of the NLRP3 inflammasome and its potential use for acute lung injury;Bioorganic Chemistry;2024-09

3. Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib;Blood Advances;2024-08-28

4. RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells;J TRANSL INTERN MED;2024

5. Therapeutic potential and recent progression of BTK inhibitors against rheumatoid arthritis;Chemical Biology & Drug Design;2024-07